MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision care company that is pioneering a new standard for managing multiple sclerosis (MS) and other ...

MENLO PARK, Calif., September 04, 2025--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision care company that is pioneering a new standard for managing multiple sclerosis (MS) and ...

Hybrid value-based behavioral healthcare provider, Octave, announced it had scored $52 million in Series C funding, bringing its total raise to $86 million. Cigna Ventures, Novo Holdings and Avidity ...